VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
IRTC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
IRTCiRhythm Technologies, Inc.
$90.22$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksIRTCBalance Sheet

iRhythm Technologies, Inc. (IRTC) Balance Sheet

13Y historyFree accessUpdated daily

Despite a high debt load of $727.3M (D/E of 3.91), the company maintains a current ratio of 3.87 and cash of $246.7M, though cash has declined from $520.4M in 2024Q1, indicating a thinning liquidity cushion.

Income StatementBalance SheetCash FlowRatios

IRTC Balance Sheet

Annual statement

IRTC Balance Sheet

iRhythm Technologies, Inc. (IRTC) balance sheet — 13-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets730.21M702.76M645.82M230.81M288.77M305.52M377.82M172.79M106.48M119.58M118.61M32.83M15.53M11.74M
Cash & Short-Term Investments560.72M583.76M535.55M133.76M213.14M239.13M335.22M140.55M78.34M102.36M106.05M25.21M8.62M7.1M
Cash Only394.72M236.01M419.6M36.17M78.83M127.56M88.63M20.46M20.02M8.67M51.64M25.21M8.62M7.1M
Short-Term Investments166M347.75M115.96M97.59M134.31M111.57M246.59M120.09M58.32M93.69M54.41M000
Accounts Receivable81.13M75.71M79.94M61.48M49.92M46.43M29.93M23.87M19.79M12.95M9.41M5.58M5.85M3.69M
Days Sales Outstanding34.436.9849.345.5544.3452.541.240.649.0547.6953.5856.3398.2387.62
Inventory23.22M21.63M14.04M13.97M15.15M10.27M5.31M4.04M2.06M1.68M1.39M1.15M818K747K
Days Inventory Outstanding35.1135.9127.831.742.7834.327.5928.0719.421.7824.2928.4328.1930.82
Other Current Assets10M21.66M16.29M21.59M10.55M9.69M7.36M4.34M4.1M2.58M91K91K00
Total Non-Current Assets361.23M317.28M285.63M202.33M159.45M157.44M133.91M133.42M13.23M13.54M19.55M5.04M2.98M1.52M
Property, Plant & Equipment214.61M193.43M172.66M153.43M136.34M140.53M118.96M116.59M9.16M6.22M4.65M2.04M751K403K
Fixed Asset Turnover4.22x3.86x3.43x3.21x3.01x2.30x2.23x1.84x16.08x15.93x13.77x17.75x28.96x38.13x
Goodwill862K862K862K862K862K862K862K862K862K862K862K862K862K862K
Intangible Assets00000000000000
Long-Term Investments290.97M69.91M61.9M3M0008.03M02.99M10.98M000
Other Non-Current Assets71.25M53.08M50.21M45.04M22.25M16.05M14.09M7.94M3.21M3.46M3.05M2.15M1.36M255K
Total Assets1.09B1.02B931.45M433.14M448.22M462.97M511.74M306.21M119.71M133.12M138.16M37.87M18.51M13.26M
Asset Turnover0.81x0.73x0.64x1.14x0.92x0.70x0.52x0.70x1.23x0.74x0.46x0.95x1.18x1.16x
Asset Growth %41.27%9.51%115.04%-3.36%-3.18%-9.53%67.12%155.79%-10.08%-3.64%264.8%104.61%39.55%-
Total Current Liabilities204.73M151.89M110.92M107.37M89.1M87.85M65.67M52.07M30.24M20.92M13.21M8.78M4.86M4.26M
Accounts Payable15.39M2.26M7.22M5.54M7.52M10.51M4.37M8.24M2.28M2.4M2.1M1.46M1.2M494K
Days Payables Outstanding16.83.7414.312.5821.2235.1122.6757.3221.493136.7636.2341.2520.38
Short-Term Debt0000011.67M11.67M1.94M01.49M0001.63M
Deferred Revenue (Current)17.13M4.2M2.93M3.31M3.05M3.05M930K1.25M1.24M1.24M947K506K00
Other Current Liabilities0662K585K1.04M18.7M1M13.96M9.75M5.81M1.38M257K0421K28K
Current Ratio3.57x4.63x5.82x2.15x3.24x3.48x5.75x3.32x3.52x5.72x8.98x3.74x3.20x2.75x
Quick Ratio3.45x4.48x5.70x2.02x3.07x3.36x5.67x3.24x3.45x5.64x8.87x3.61x3.03x2.58x
Cash Conversion Cycle52.7169.1562.864.6865.951.6946.1211.3546.9638.4841.1248.5385.1798.06
Total Non-Current Liabilities709.6M715.41M729.62M115.68M119.31M95.6M104.46M118.74M35.05M32.65M32.38M130.72M6.38M4.4M
Long-Term Debt651.86M649.5M646.44M34.95M34.94M9.69M21.34M32.99M34.9M32.49M32.23M30.55M6.25M4.21M
Capital Lease Obligations243.36M64.99M74.6M79.72M83.07M85.21M81.29M85.75M000000
Deferred Tax Liabilities00000000000000
Other Non-Current Liabilities908K908K8.58M1.01M1.31M697K1.83M0153K161K152K100.17M130K190K
Total Liabilities914.34M867.3M840.54M223.05M208.41M183.45M170.13M170.8M65.29M53.57M45.59M139.5M11.24M8.66M
Total Debt725.73M731.18M736.91M129.82M131.04M117.71M122.47M128.59M34.9M33.98M32.23M30.55M6.25M5.84M
Net Debt331.02M495.17M317.31M93.65M52.21M-9.85M33.84M108.13M14.88M25.31M-19.42M5.34M-2.36M-1.26M
Debt / Equity4.10x4.79x8.11x0.62x0.55x0.42x0.36x0.95x0.64x0.43x0.35x-0.86x1.27x
Debt / EBITDA-56.54x-------------
Net Debt / EBITDA-25.79x-------------
Interest Coverage-1.85x-2.31x-7.79x-32.60x-27.01x-85.39x-27.70x-32.17x-15.16x-7.78x-5.44x-20.53x-19.45x-
Total Equity177.11M152.75M90.91M210.1M239.81M279.51M341.61M135.41M54.42M79.55M92.56M-101.62M7.26M4.6M
Equity Growth %278.75%68.02%-56.73%-12.39%-14.2%-18.18%152.28%148.81%-31.59%-14.05%191.08%-1499.01%57.91%-
Book Value per Share5.354.772.916.888.029.5312.315.362.283.5217.51-6.880.493.62
Total Shareholders' Equity177.11M152.75M90.91M210.1M239.81M279.51M341.61M135.41M54.42M79.55M92.56M-101.62M7.26M4.6M
Common Stock33K32K31K31K28K27K27K25K23K23K22K1K8K8K
Retained Earnings-847.61M-803.45M-758.89M-645.61M-522.2M-406.05M-304.68M-260.39M-203.51M-156.59M-127.17M-106.27M-83.47M-67.64M
Treasury Stock-25M-25M-25M00000000-4.64M00
Accumulated OCI-216K403K165K-112K-396K-61K11K82K-41K-65K-9K-1.08M00
Minority Interest00000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Reimbursement and regulatory overhang

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Equity Erosion Amid Revenue Growth

Despite 26% revenue growth, IRTC's equity fell from $90.3M in 2024Q1 to $186.0M in 2026Q2, but total liabilities rose 10.7%, indicating balance sheet strain, per reported financials.

The equity base has expanded from $90.3M to $186.0M over the period, but this is largely due to capital raises and retained losses, not organic profitability. Total liabilities increased from $819.5M to $906.9M, with debt remaining elevated near $727M, suggesting the company is funding growth through leverage. The trajectory implies that while revenue accelerates, the balance sheet is not yet self-sustaining, and investors should monitor whether equity growth can outpace liability accumulation.

Leverage Persists Despite Cash Buffer

IRTC's debt-to-equity ratio improved from 8.16 in 2024Q1 to 3.91 in 2026Q2, but total debt remains high at $727.3M, with cash of $246.7M, indicating a strategic reliance on debt financing, as per SEC filings.

The D/E ratio has halved, but this is primarily due to equity growth from capital raises, not debt reduction. Total debt has remained remarkably stable around $727-737M across ten quarters, suggesting the company is not aggressively deleveraging. With cash at $246.7M, the net debt position is approximately $480.6M, which appears manageable given the improving operating cash flow, but the fixed interest burden could strain margins if revenue growth stalls.

Asset Mix Shifts Toward Tangibles

PPE net increased 27.3% from $160.3M in 2024Q1 to $204.1M in 2026Q2, while goodwill remains minimal at $862K, indicating an asset-light model with growing investment in physical infrastructure, based on reported figures.

The increase in PPE suggests investment in manufacturing capacity or clinical operations, which aligns with the company's scaling efforts. Goodwill is negligible, implying that past acquisitions have not created significant intangible risk. The asset mix remains heavily weighted toward current assets, with a current ratio of 3.87, but the growing PPE base may signal a shift toward a more capital-intensive model, which could pressure future cash flows if not matched by revenue growth.

Retained Losses Mask Equity Quality

Accumulated deficit deepened to -$817.8M in 2026Q2 from -$691.3M in 2024Q1, yet equity rose to $186.0M, implying equity quality is driven by external capital, not retained earnings, as reported in financial statements.

The retained earnings deficit has grown by $126.5M over the period, reflecting cumulative losses, but equity has increased due to capital infusions. This suggests that the equity base is not organically generated, and the company remains dependent on external financing to support its balance sheet. Investors should monitor whether the narrowing operating losses can eventually reverse the retained earnings trend, which would signal a more sustainable equity structure.

Liquidity Buffer Thins as Cash Declines

Cash fell from $520.4M in 2024Q1 to $246.7M in 2026Q2, while the current ratio dropped from 7.10 to 3.87, indicating a shrinking liquidity cushion despite still-adequate coverage, per quarterly disclosures.

The cash balance has more than halved, reflecting significant cash burn in operations and investments, though operating cash flow turned positive in recent quarters. The current ratio remains above 3, providing a buffer, but the trend is concerning. With cash runway estimated at roughly 12 months based on current burn, the company may need to raise additional capital or achieve sustained profitability to avoid liquidity strain.

Debt Maturity and Refinancing Risk

Total debt of $727.3M with a D/E of 3.91 appears manageable, but the stability of debt levels over ten quarters suggests potential refinancing needs, which could be costly in a high-rate environment, as per reported balance sheets.

The debt has remained consistently around $730M, indicating that the company may have a term loan or convertible notes that are not being amortized. If this debt matures in the near term, refinancing at current interest rates could increase interest expense and pressure cash flows. Additionally, the company's lack of GAAP profitability may limit its access to favorable debt terms, making equity issuance a more likely path, which could dilute shareholders.

IRTC — Frequently Asked Questions

Quick answers to the most common questions about buying IRTC stock.

What are the total assets of iRhythm Technologies, Inc. (IRTC)?

As of 2025, iRhythm Technologies, Inc. (IRTC) had total assets of $1.02B including $702.8M in current assets.

How much debt does iRhythm Technologies, Inc. (IRTC) have?

iRhythm Technologies, Inc. (IRTC) carries total debt of $731.2M, offset by $583.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of iRhythm Technologies, Inc.?

iRhythm Technologies, Inc. (IRTC) has total shareholders' equity (book value) of $152.7M ($4.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is iRhythm Technologies, Inc.'s current ratio and liquidity?

iRhythm Technologies, Inc. (IRTC) reported a current ratio of 4.63x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.